In this episode, Drs William J. Gradishar, Heather McArthur, and Joanne Mortimer address audience questions from a recent live event on the use of CDK4/6 inhibitors in patients with early and metastatic breast cancer, including: Genomic testing options for assessing risk of recurrence Adjuvant treatment duration and holidays with CDK4/6 inhibitors Managing renal toxicities, prophylaxis for DVT, and asymptomatic ILD CDK4/6 inhibitors with inavolisib and fulvestrant Presenters: William J. Gradishar, MD, FACP, FASCO Betsy Bramsen Professor of Breast Oncology Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago, Illinois Heather McArthur, MD, MPH, FASCO Professor, Department of Internal Medicine Clinical Director, Breast Cancer Program Komen Distinguished Chair in Clinical Breast Cancer Research UT Southwestern Medical Center Dallas, Texas Joanne Mortimer, MD, FACP, FASCO Vice Chair, Medical Oncology Professor, Division of Medical Oncology & Experimental Therapeutics Associate Director for Education and Training Baum Family Professor of Women’s Cancers City of Hope Comprehensive Cancer Center Duarte, California Link to full program: https://bit.ly/4osHLTm Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
